Two
Industry-Leading
Technologies
ASEP offers a rare combination of both a novel diagnostic and a therapeutic approach to a multibillion-dollar problem.
Diagnostic
The problem:
Delayed diagnosis.
Blood cultures take 24 hours for results. Every hour delay in diagnosis and appropriate treatment increases the probability of death 7.6%.
The solution:
Gene-signature-
based test.
Provides reliable diagnosis in 1 hour, with more sensitivity and specificity than the SIRS or Sepsis 3 criteria used today.
Therapeutic
The problem:
Ineffective treatment
Biofilms are associated with 65% of all infections. There is currently no effective treatment.
The solution:
Proprietary peptide technology.
Provides broad spectrum efficacy against bacteria growing antibiotic-resistant biofilms.